0001022079-16-000251.txt : 20160427 0001022079-16-000251.hdr.sgml : 20160427 20160427085824 ACCESSION NUMBER: 0001022079-16-000251 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160427 DATE AS OF CHANGE: 20160427 EFFECTIVENESS DATE: 20160427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 161593566 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 DEFA14A 1 dgx42716defa14a.htm DEFA14A DEFA14A


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant   [X]
Filed by a Party other than the Registrant   [_]

Check the appropriate box:
[_]
Preliminary Proxy Statement
[_]
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2))
[_]
Definitive Proxy Statement
[X]
Definitive Additional Materials
[_]
Soliciting Material Pursuant to Section 240.14a-12

Quest Diagnostics Incorporated



(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
[X]
No fee required.
[_]
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 
 
1)
Title of each class of securities to which transaction applies:
 
 
2)
Aggregate number of securities to which transaction applies:



 
3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):



 
4)
Proposed maximum aggregate value of transaction:
 
 
5)
Total fee paid:
 
 
[_]
Fee paid previously with preliminary materials:
 
 
[_] 
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
 
 
 
1) Amount previously paid:
 
 
 
2) Form, Schedule or Registration Statement No.: 
 
 
 
3) Filing Party:
 
 
 
4) Date Filed:




On April 27, 2016, Quest Diagnostics Incorporated (the “Company”) provided the following supplemental information:
The attendance of Jeffrey M. Leiden at meetings of the Board of Directors (the “Board”) of the Company, and meetings of the committees of the Board, was limited in 2015 to 74 percent of the total meetings of the Board and such committees. Dr. Leiden missed 5 meetings or calls in 2015; 4 of these were missed due to travel difficulties, including flight cancellation, beyond his control.